Antibodies to IL-17A and uses thereof
US8865166B2 · kind B2 · utility
5Cited by
1References
8Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 22, 2007 |
| Grant date | Oct 21, 2014 |
| Priority date | — |
| Expiry date | Nov 1, 2030 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/92
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Binding members, especially antibody molecules, for interleukin 17 (IL-17). The binding members are useful for the treatment of disorders associated with interleukin 17 such as rheumatoid arthritis.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.